(Q42279681)

19 October 2017

Nanoparticles encapsulating hepatitis B virus cytosine-phosphate-guanosine induce therapeutic immunity against HBV infection (English)

1 reference

19 October 2017

1 reference

1 reference

2

1 reference

19 October 2017

Shujuan Lv

1

1 reference

19 October 2017

Shuang Dou

3

1 reference

19 October 2017

Xianzhu Yang

4

1 reference

19 October 2017

Xiang Ni

5

1 reference

19 October 2017

Rui Sun

6

1 reference

19 October 2017

Zhigang Tian

7

1 reference

19 October 2017

Haiming Wei

8

1 reference

19 October 2017

language of work or name

English

0 references

publication date

20 December 2013

1 reference

19 October 2017

1 reference

19 October 2017

59

1 reference

19 October 2017

2

1 reference

19 October 2017

385-394

1 reference

19 October 2017

1 reference

Immunology of hepatitis B virus and hepatitis C virus infection

21 January 2018

1 reference

Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition

21 January 2018

1 reference

Plasmacytoid dendritic cells: sensing nucleic acids in viral infection and autoimmune diseases.

21 January 2018

1 reference

Cutting edge: Role of Toll-like receptor 9 in CpG DNA-induced activation of human cells

21 January 2018

1 reference

Interactions between bacterial CpG-DNA and TLR9 bridge innate and adaptive immunity

21 January 2018

1 reference

Therapeutic potential of Toll-like receptor 9 activation

21 January 2018

1 reference

Phase 1B, randomized, double-blind, dose-escalation trial of CPG 10101 in patients with chronic hepatitis C virus

21 January 2018

1 reference

Prospects for prophylactic and therapeutic vaccines against the hepatitis C viruses

21 January 2018

1 reference

Lymphoid follicle destruction and immunosuppression after repeated CpG oligodeoxynucleotide administration

21 January 2018

1 reference

Virus or TLR agonists induce TRAIL-mediated cytotoxic activity of plasmacytoid dendritic cells.

21 January 2018

1 reference

An immunocompetent mouse model for the tolerance of human chronic hepatitis B virus infection

21 January 2018

1 reference

IPC: professional type 1 interferon-producing cells and plasmacytoid dendritic cell precursors

21 January 2018

1 reference

Plasmacytoid dendritic cells in immunity

21 January 2018

1 reference

Aggregation and secondary loop structure of oligonucleotides do not determine their ability to inhibit TLR9

21 January 2018

1 reference

Repetitive elements in mammalian telomeres suppress bacterial DNA-induced immune activation

21 January 2018

1 reference

The immune response during hepatitis B virus infection

21 January 2018

1 reference

TLR9 signals after translocating from the ER to CpG DNA in the lysosome

21 January 2018

1 reference

Systemic delivery of siRNA with cationic lipid assisted PEG-PLA nanoparticles for cancer therapy

21 January 2018

1 reference

Experimental models and therapeutic approaches for HBV.

21 January 2018

1 reference

Decreased frequency and function of circulating plasmocytoid dendritic cells (pDC) in hepatitis B virus infected humans

21 January 2018

1 reference

Hepatitis B virus impairs TLR9 expression and function in plasmacytoid dendritic cells.

21 January 2018

1 reference

CpG oligonucleotides as adjuvants for vaccines targeting infectious diseases.

21 January 2018

1 reference

Plasmids enriched with CpG motifs activate human peripheral blood mononuclear cells in vitro and enhance th-1 immune responses to hepatitis B surface antigen in mice.

21 January 2018

1 reference

Hepatitis B virus: from immunobiology to immunotherapy

21 January 2018

1 reference

Plasmacytoid dendritic cells prime IL-10-producing T regulatory cells by inducible costimulator ligand

21 January 2018

1 reference

CPG 7909, an immunostimulatory TLR9 agonist oligodeoxynucleotide, as adjuvant to Engerix-B HBV vaccine in healthy adults: a double-blind phase I/II study

21 January 2018

1 reference

7 January 2021

CpG still rocks! Update on an accidental drug

1 reference

7 January 2021

Altered functions of plasmacytoid dendritic cells and reduced cytolytic activity of natural killer cells in patients with chronic HBV infection

1 reference

7 January 2021

Encapsulating immunostimulatory CpG oligonucleotides in listeriolysin O-liposomes promotes a Th1-type response and CTL activity

1 reference

7 January 2021

CpG oligodeoxynucleotide-adjuvanted fusion peptide derived from HBcAg epitope and HIV-Tat may elicit favorable immune response in PBMCs from patients with chronic HBV infection in the immunotolerant phase

1 reference

7 January 2021

Identifiers

DOI

10.1002/HEP.26654

1 reference

19 October 2017

1 reference